These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8905171)

  • 1. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.
    Nakanishi H; Katsuta K; Ueda Y; Takasugi H; Kuno A; Ohkubo M; Ogita K; Yoneda Y; Shirakawa K; Yoshida K
    Psychopharmacology (Berl); 1995 Jan; 117(2):172-7. PubMed ID: 7753964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist.
    Hodgkiss JP; Sherriffs HJ; Cottrell DA; Shirakawa K; Kelly JS; Kuno A; Ohkubo M; Butcher SP; Olverman HJ
    Eur J Pharmacol; 1993 Aug; 240(2-3):219-27. PubMed ID: 7902282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-competitive NMDA antagonists, FR115427 and MK801, enhance neuronal survival in primary culture.
    Ueda Y; Katsuta K; Nakanishi H; Yoshida K
    Neurosci Lett; 1995 Feb; 185(2):107-10. PubMed ID: 7746498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex.
    Clow DW; Lee SJ; Hammer RP
    Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the binding of [3H]FR115427, a novel non-competitive NMDA receptor antagonist, to rat brain membranes.
    Sherriffs HJ; Shirakawa K; Kelly JS; Olverman HJ; Kuno A; Okubo M; Butcher SP
    Eur J Pharmacol; 1993 Nov; 247(3):319-24. PubMed ID: 8307103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats following unilateral lesion of caudal entorhinal cortex.
    Kurumaji A; McCulloch J
    Brain Res; 1990 Oct; 531(1-2):72-82. PubMed ID: 2289138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
    Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.
    Hargreaves RJ; Rigby M; Smith D; Hill RG
    Br J Pharmacol; 1993 Sep; 110(1):36-42. PubMed ID: 8220897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain.
    Gao XM; Tamminga CA
    J Neural Transm Gen Sect; 1995; 101(1-3):105-13. PubMed ID: 8695041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.
    Nehls DG; Kurumaji A; Park CK; McCulloch J
    Neurosci Lett; 1988 Aug; 91(2):204-10. PubMed ID: 2847086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine.
    Bakshi VP; Geyer MA
    J Neurosci; 1998 Oct; 18(20):8394-401. PubMed ID: 9763482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.
    Kurumaji A; McCulloch J
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):786-94. PubMed ID: 2684992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebroventricular application of competitive and non-competitive NMDA antagonists induce similar effects upon rat hippocampal electroencephalogram and local cerebral glucose utilization.
    Boddeke HW; Wiederhold KH; Palacios JM
    Brain Res; 1992 Jul; 585(1-2):177-83. PubMed ID: 1511299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.
    Hashimoto K; Tomitaka S; Bi Y; Narita N; Minabe Y; Iyo M
    Eur J Neurosci; 1997 Sep; 9(9):1891-901. PubMed ID: 9383212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral glucose utilization in transgenic mice overexpressing heat shock protein 70 is altered by dizocilpine.
    Kelly S; Bieneman A; Uney JB; McCulloch J
    Eur J Neurosci; 2002 Mar; 15(6):945-52. PubMed ID: 11918653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex.
    Kurumaji A; Ikeda M; Dewar D; McCormack AG; McCulloch J
    Brain Res; 1991 Nov; 563(1-2):57-65. PubMed ID: 1838495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.